ADVANCED UROTHELIAL CARCINOMA

Clinical trials for ADVANCED UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 5 Terminated 1

Two-Drug attack tested for Tough-to-Treat bladder cancer

Disease control Terminated

This early-phase study tested a combination of two drugs, selinexor and pembrolizumab, for patients with advanced bladder cancer who could not receive or did not respond to standard chemotherapy. The goal was to find a safe dose and see if the combination could shrink tumors. The…

Matched conditions: ADVANCED UROTHELIAL CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Mamta Parikh • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

ADVANCED UROTHELIAL CARCINOMA

Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear

Two-Drug attack tested for Tough-to-Treat bladder cancer